Omega-3 deficiency associated with perinatal depression: Case control study

Psychiatry Research

Volumn 166, Issue 2-3, 2009, Pages 254-259

  Rees, Anne Marie ^a   Austin, Marie Paule ^a   Owen, Catherine ^a   Parker, Gordon ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Depression; Docosahexaenoic acids; Fatty acids; Postnatal depression; Pregnancy; Unsaturated

Indexed keywords

DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HAMILTON SCALE; HUMAN; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; THIRD TRIMESTER PREGNANCY;

ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GAS; DEPRESSION; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; RISK FACTORS;

EID: 62549129026     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.12.011     Document Type: Article

References (24)

1. Al M.D.M., van Houwelingen A.C., Kester A.D.M., Hasaart T.H.M., de Jong A.E.P., and Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and its relationship with the neonatal essential fatty acid status. British Journal of Nutrition 74 (1994) 55-60
2. Austin M.-P. To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects. Psychological Medicine 36 (2006) 1663-1670
3. Cox J., Holden J., and Sagovsky R. Detection of postnatal depression, development of the Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 150 (1987) 782-786
4. De Vriese S.R., Christophe A.B., and Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sciences 73 (2003) 3181-3187
5. Evans J., Heron J., Francomb H., Oke S., and Golding J. Cohort study (ALSPAC) of depressed mood during pregnancy and after childbirth. British Medical Journal 323 (2001) 257-260
6. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 67 (2006) 1954-1967
7. Freeman M.P., Hibbeln J.R., Wisner K.L., Brumbach B.H., Watchman M., and Gelenberg A.J. Randomised dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatrica Scandinavia 113 (2006) 31-35
8. Green J., and Murray D. The use of the Edinburgh Postnatal Depression Scale in research to explore the relationship between antenatal and postnatal dysphoria. In: Cox J., and Holden J. (Eds). Perinatal Psychiatry (1994), Gaskell, London 180
9. Hamilton M. Hamilton Depression Scale. In: Guy W. (Ed). ECDEU Assessment Manual for Psychopharmacology. Rev ed. (1976), National Institute of Mental Health, Rockville, MD 179-192
10. Hibbeln J.R. Fish consumption and major depression. Lancet 351 (1998) 1213
11. Hibbeln J.R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. Journal of Affective Disorders 69 (2002) 15-29
12. Hibbeln J., Davis J., Heron J., Evans J., Wolke D., and Golding J. Low dietary omega-3s increased depression risk in 14,541 pregnancies. In: American Psychiatric Association (Ed). New Research Abstracts, Annual Meeting of the American Psychiatric Association (2003), The Association, Washington, D.C.
13. Holub B.J. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. Canadian Medical Association Journal 166 (2002) 608-615
14. Hornstra G. Essential fatty acids in mothers and their neonates. American Journal of Clinical Nutrition 71 (2000) 1262S-1269S
15. Innis S. Perinatal biochemistry and physiology of long chain PUFA. Journal of Pediatrics 143 (2003) S1-S8
16. Meyer B., Mann N., Lewis J., Milligan G.C., Sinclair A.J., and Howe P.R. Dietary intakes and food sources of omega 6 and omega 3 polyunsaturated fatty acids. Lipids 38 (2003) 391-398
17. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134 (1979) 382-389
18. Otto J., De Groot R.H.M., and Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalisation after pregnancy of the functional docosahexaenoic acid status. Prostaglandins, Leukotrienes and Essential Fatty Acids 69 (2003) 237-243
19. Parker G.B., Gibson N., Brotchie H., Heruc G., Rees A.-M., and Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. American Journal of Psychiatry 163 (2006) 969-978
20. Parker G.B., Heruc G.A., Hilton T.M., Olley A., Brotchie H., Hadzi-Pavlovic D., Friend C., Walsh W.F., and Stocker R. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. Psychiatry Research 141 (2006) 279-286
21. Rees A.-M., Austin M.-P., and Parker G. Role of omega-3 fatty acids in the treatment of depression in the perinatal period. Australian and New Zealand Journal of Psychiatry 39 (2005) 274-281
22. Ross B. n-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality on phospholipid metabolism. Medical Hypotheses 68 (2007) 515-524
23. van den Ham E.C., van Houwelingen A.C., and Hornstra G. Evaluation of the relation between n-3 and n-6 fatty acid status and parity in non-pregnant women from the Netherlands. American Journal of Clinical Psychiatry 73 (2001) 622-627
24. World Health Organisation. Composite International Diagnostic Interview (CIDI) Autoversion 2.1. Administrator's Guide (1997), WHO, Sydney